HedgeMountain

Stepstone Group LP

La Jolla, CA · CRD 143635
Hedge fund manager

Stepstone Group LP is an SEC-registered investment adviser based in La Jolla, CA that reports managing 1 hedge fund on Form ADV. It reports $107.8 billion in regulatory assets under management. Its private funds, of all types, hold $123.3 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated -26.7% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated -9.9% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.

Regulatory assets under management
$107.8 billionForm ADV Item 5.F
Gross assets of private funds
$123.3 billionAll private fund types, Form ADV
Hedge funds managed
1409 private funds in total
Employees
978Form ADV Item 5.A
Registration
SEC-registered adviserCRD 143635
Latest Form ADV
07/30/2026Disciplinary disclosures: none reported

Estimated 13F portfolio performance

Est. 2026 YTD-26.7%Through Q2 2026 · S&P 500 +9.5%
Est. 2-year return-9.9%Q3 2024 – Q2 2026
S&P 500+37.2%Same quarters, price only
13F holdings$2.2 billion23 positions, 2026-06-30
$75$109$143Q3 2024Q1 2025Q3 2025Q1 202613F est. $90S&P 500 $137
QuarterEst. 13F returnS&P 500
Q2 2026+19.4%+14.8%
Q1 2026-38.6%-4.6%
Q4 2025-6.7%+2.4%
Q3 2025+0.0%+7.8%
Q2 2025+4.8%+10.4%
Q1 2025-12.4%-4.5%
Q4 2024+27.5%+2.1%
Q3 2024+12.5%+5.4%

Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures

Largest disclosed holdings

  • 84615q103$1.9 billion
  • Stubhub Holdings Inc CL A$97.3 million
  • 15675d103$75.2 million
  • 98390r102$41.4 million
  • 87821b109$16.4 million
  • Onkure Therapeutics Inc$12.1 million
  • Karman Hldgs Inc$12.0 million
  • Kodiak Ai Inc.$7.2 million
  • Entrada Therapeutics Inc$5.6 million
  • 282564103$5.2 million

As of 2026-06-30, from 13F filing by StepStone Group LP.

From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. HedgeMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures